KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,491,640 | +22.9% | 373,721 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $5,281,852 | +30.1% | 375,109 | -0.6% | 0.00% | +100.0% |
| Q1 2023 | $4,059,236 | +68887.7% | 377,258 | -4.0% | 0.00% | -50.0% |
| Q4 2022 | $5,884 | -99.9% | 392,791 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $5,052,000 | +28.0% | 393,466 | -3.4% | 0.00% | +100.0% |
| Q2 2022 | $3,946,000 | +10.0% | 407,147 | +12.8% | 0.00% | 0.0% |
| Q1 2022 | $3,588,000 | +91.4% | 360,940 | +126.6% | 0.00% | 0.0% |
| Q4 2021 | $1,875,000 | +22.5% | 159,318 | +18.6% | 0.00% | – |
| Q3 2021 | $1,530,000 | -66.5% | 134,287 | -59.1% | 0.00% | -100.0% |
| Q2 2021 | $4,572,000 | +3.8% | 328,214 | +37.9% | 0.00% | 0.0% |
| Q1 2021 | $4,406,000 | +233.0% | 238,047 | +218.0% | 0.00% | – |
| Q4 2020 | $1,323,000 | +23.0% | 74,856 | +6.6% | 0.00% | – |
| Q3 2020 | $1,076,000 | -35.1% | 70,247 | +7.9% | 0.00% | -100.0% |
| Q2 2020 | $1,659,000 | +63.3% | 65,080 | -1.2% | 0.00% | 0.0% |
| Q1 2020 | $1,016,000 | +244.4% | 65,871 | +146.8% | 0.00% | – |
| Q4 2019 | $295,000 | – | 26,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |